Process View
A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the stopping or reduction in rate of the cell cycle.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| Trp53 | transformation related protein 53 | 1.000 | ||
| Trp63 | transformation related protein 63 | 0.940 | Mouse | |
| Ctnnb1 | catenin (cadherin associated protein), beta 1 | 0.925 | ||
| Mdm2 | transformed mouse 3T3 cell double minute 2 | 0.910 | Human | |
| Mdm4 | transformed mouse 3T3 cell double minute 4 | 0.907 | ||
| Apc | adenomatosis polyposis coli | 0.881 | ||
| Rb1 | retinoblastoma 1 | 0.867 | ||
| Pten | phosphatase and tensin homolog | 0.845 | ||
| Kras | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.775 | ||
| Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.597 | Human | |
| Kit | kit oncogene | 0.528 | ||
| Trp73 | transformation related protein 73 | 0.479 | Mouse | |
| Col1a1 | collagen, type I, alpha 1 | 0.436 | ||
| Cdkn2a | cyclin-dependent kinase inhibitor 2A | 0.410 | ||
| Rara | retinoic acid receptor, alpha | 0.402 | ||
| Brca1 | breast cancer 1 | 0.383 | ||
| Daxx | Fas death domain-associated protein | 0.321 | ||
| Cdkn1b | cyclin-dependent kinase inhibitor 1B | 0.317 | ||
| Sox9 | SRY-box containing gene 9 | 0.296 | ||
| Thbs1 | thrombospondin 1 | 0.288 | ||
| Fgfr2 | fibroblast growth factor receptor 2 | 0.265 | ||
| Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.261 | ||
| Nfe2l2 | nuclear factor, erythroid derived 2, like 2 | 0.241 | ||
| Braf | Braf transforming gene | 0.224 | ||
| Meox2 | mesenchyme homeobox 2 | 0.182 | ||
| Vhl | von Hippel-Lindau tumor suppressor | 0.169 | ||
| Sfn | stratifin | 0.135 | ||
| Rxra | retinoid X receptor alpha | 0.132 | ||
| Skil | SKI-like | 0.130 | ||
| Esr2 | estrogen receptor 2 (beta) | 0.118 | ||
| Runx1 | runt related transcription factor 1 | 0.107 | ||
| Nf1 | neurofibromatosis 1 | 0.096 | ||
| Hif1a | hypoxia inducible factor 1, alpha subunit | 0.088 | ||
| Cdkn2c | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.075 | ||
| Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.075 | ||
| Brca2 | breast cancer 2 | 0.075 | ||
| Ptch1 | patched homolog 1 | 0.073 | ||
| Rag1 | recombination activating gene 1 | 0.072 | ||
| Psen1 | presenilin 1 | 0.072 | ||
| Esr1 | estrogen receptor 1 (alpha) | 0.060 | ||
| E2f1 | E2F transcription factor 1 | 0.053 | ||
| Nf2 | neurofibromatosis 2 | 0.051 | ||
| Stk11 | serine/threonine kinase 11 | 0.047 | ||
| Ahr | aryl-hydrocarbon receptor | 0.045 | ||
| Ccnd1 | cyclin D1 | 0.043 | ||
| Shh | sonic hedgehog | 0.043 | ||
| Gadd45a | growth arrest and DNA-damage-inducible 45 alpha | 0.040 | ||
| Dsc3 | desmocollin 3 | 0.038 | ||
| Emx2 | empty spiracles homolog 2 (Drosophila) | 0.034 | ||
| Krt14 | keratin 14 | 0.034 | ||
| Prkdc | protein kinase, DNA activated, catalytic polypeptide | 0.034 | ||
| Hipk1 | homeodomain interacting protein kinase 1 | 0.033 | ||
| Smn1 | survival motor neuron 1 | 0.031 | ||
| Smad3 | MAD homolog 3 (Drosophila) | 0.031 | ||
| Elavl1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) | 0.030 | ||
| Rbl1 | retinoblastoma-like 1 (p107) | 0.027 | ||
| Vegfa | vascular endothelial growth factor A | 0.027 | ||
| Atm | ataxia telangiectasia mutated homolog (human) | 0.026 | ||
| Irf6 | interferon regulatory factor 6 | 0.026 | ||
| Mybl2 | myeloblastosis oncogene-like 2 | 0.026 | ||
| Hr | hairless | 0.025 | ||
| Gli3 | GLI-Kruppel family member GLI3 | 0.025 | ||
| Tsc1 | tuberous sclerosis 1 | 0.025 | ||
| Yap1 | yes-associated protein 1 | 0.024 | ||
| Xpa | xeroderma pigmentosum, complementation group A | 0.020 | ||
| Hhat | hedgehog acyltransferase | 0.019 | ||
| Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.019 | ||
| Cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.018 | ||
| Msh2 | mutS homolog 2 (E. coli) | 0.017 | ||
| Lef1 | lymphoid enhancer binding factor 1 | 0.017 | ||
| Hprt | hypoxanthine guanine phosphoribosyl transferase | 0.017 | ||
| Mmp14 | matrix metallopeptidase 14 (membrane-inserted) | 0.017 | ||
| Tcf3 | transcription factor 3 | 0.016 | ||
| Nfya | nuclear transcription factor-Y alpha | 0.016 | ||
| Rarb | retinoic acid receptor, beta | 0.016 | ||
| Pdgfra | platelet derived growth factor receptor, alpha polypeptide | 0.016 | ||
| Bcl2 | B-cell leukemia/lymphoma 2 | 0.015 | ||
| Mta2 | metastasis-associated gene family, member 2 | 0.014 | ||
| Notch2 | Notch gene homolog 2 (Drosophila) | 0.014 | ||
| Sin3a | transcriptional regulator, SIN3A (yeast) | 0.013 | ||
| Gata3 | GATA binding protein 3 | 0.013 | ||
| Cdk2 | cyclin-dependent kinase 2 | 0.013 | ||
| Kitl | kit ligand | 0.013 | ||
| Cdx2 | caudal type homeobox 2 | 0.012 | ||
| Men1 | multiple endocrine neoplasia 1 | 0.012 | ||
| Isl1 | ISL1 transcription factor, LIM/homeodomain | 0.012 | ||
| Cyp21a1 | cytochrome P450, family 21, subfamily a, polypeptide 1 | 0.011 | ||
| Tgfb1 | transforming growth factor, beta 1 | 0.011 | ||
| Rnf111 | ring finger 111 | 0.011 | ||
| Egfr | epidermal growth factor receptor | 0.011 | ||
| Krt19 | keratin 19 | 0.011 | ||
| Cxcr4 | chemokine (C-X-C motif) receptor 4 | 0.011 | ||
| Ar | androgen receptor | 0.011 | ||
| Bard1 | BRCA1 associated RING domain 1 | 0.011 | ||
| Bcl2l1 | BCL2-like 1 | 0.011 | ||
| Lrp6 | low density lipoprotein receptor-related protein 6 | 0.011 | ||
| Adam17 | a disintegrin and metallopeptidase domain 17 | 0.010 | ||
| Gtse1 | G two S phase expressed protein 1 | 0.010 | ||
| Lrdd | leucine-rich and death domain containing | 0.010 | Human | |
| Wrn | Werner syndrome homolog (human) | 0.010 | ||
| Trpc2 | transient receptor potential cation channel, subfamily C, member 2 | 0.010 |